Advertisements

D'Incalci, Maurizio

Humanitas University, Italy

2023 Rank: 37,684

Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:

Clinical Medicine

SubField 1:

Oncology & Carcinogenesis

SubField 2:

Pharmacology & Pharmacy

Rank in SubField 1: 1,686 out of 312,644 Researchers

Data For The Year: 2023
Metrics Self-Citations Excluded All
Rank Based on Composite Score37,68437,498
Total Cites16,13219,049
H-index6570
Hm-index2628
Number of Single Authored Papers1515
Total Cites to Single Authored Papers7583
Number of Single+First Authored Papers7070
Total Cites to Single+First Authored Papers1,3101,461
Number of Single+First+Last Authored Papers277277
Total Cites to Single+First+Last Authored Papers6,6547,589
Composite Score33
Number of Distinct Citing Papers12,37913,563
Ratio of Total Citations to Distinct Citing Papers 1.30 1.40
Self-Citation Percentage
15.31%
Found an error in your data? Contact us with your profile link. Contact Us →

D'Incalci, Maurizio

Humanitas University, Italy

2022 Rank: 38,669

Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:

Clinical Medicine

SubField 1:

Oncology & Carcinogenesis

SubField 2:

Pharmacology & Pharmacy

Rank in SubField 1: 1,732 out of 293,195 Researchers

Data For The Year: 2022
Metrics Self-Citations Excluded All
Rank Based on Composite Score38,66938,163
Total Cites14,83117,603
H-index6166
Hm-index2426
Number of Single Authored Papers1515
Total Cites to Single Authored Papers6775
Number of Single+First Authored Papers7070
Total Cites to Single+First Authored Papers1,2241,369
Number of Single+First+Last Authored Papers272272
Total Cites to Single+First+Last Authored Papers6,2787,186
Composite Score33
Number of Distinct Citing Papers11,33312,451
Ratio of Total Citations to Distinct Citing Papers 1.31 1.41
Self-Citation Percentage
15.75%
Found an error in your data? Contact us with your profile link. Contact Us →

D'Incalci, Maurizio

Istituto di Ricerche Farmacologiche Mario Negri, Italy

2021 Rank: 39,136

Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:

Clinical Medicine

SubField 1:

Oncology & Carcinogenesis

SubField 2:

Pharmacology & Pharmacy

Rank in SubField 1: 1,748 out of 271,773 Researchers

Data For The Year: 2021
Metrics Self-Citations Excluded All
Rank Based on Composite Score39,13638,159
Total Cites13,97516,560
H-index5864
Hm-index2325
Number of Single Authored Papers1515
Total Cites to Single Authored Papers6875
Number of Single+First Authored Papers7070
Total Cites to Single+First Authored Papers1,2011,341
Number of Single+First+Last Authored Papers265265
Total Cites to Single+First+Last Authored Papers5,9046,735
Composite Score33
Number of Distinct Citing Papers10,66611,730
Ratio of Total Citations to Distinct Citing Papers 1.31 1.41
Self-Citation Percentage
15.61%
Found an error in your data? Contact us with your profile link. Contact Us →

D'Incalci, Maurizio

Istituto di Ricerche Farmacologiche Mario Negri, Italy

2020 Rank: 38,245

Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:

Clinical Medicine

SubField 1:

Oncology & Carcinogenesis

SubField 2:

Pharmacology & Pharmacy

Rank in SubField 1: 1,794 out of 230,678 Researchers

Data For The Year: 2020
Metrics Self-Citations Excluded All
Rank Based on Composite Score38,24537,030
Total Cites12,65915,068
H-index5663
Hm-index2224
Number of Single Authored Papers1515
Total Cites to Single Authored Papers6369
Number of Single+First Authored Papers7070
Total Cites to Single+First Authored Papers1,1281,259
Number of Single+First+Last Authored Papers261261
Total Cites to Single+First+Last Authored Papers5,5466,334
Composite Score33
Number of Distinct Citing Papers9,60810,593
Ratio of Total Citations to Distinct Citing Papers 1.32 1.42
Self-Citation Percentage
15.99%
Found an error in your data? Contact us with your profile link. Contact Us →
Advertisements

Partner with TOPSCINET

Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.

Advertisements